Essentially 300 international authorities present the New Edition of the standard reference for cardiovascular drug therapy. Those available cardiovascular drugs and those on the horizon are discussed - making Cardiovascular Drug Therapy, 2/e the resource cardiologists will turn to first to find out what's available and most effective.

Features

Divides coverage into two distinct parts...Therapeutic Strategies in Patients and Disease and Cardiovascular Drugs, so practitioners can not only explore proven-successful drug treatments, but also familiarize themselves with the individual drug classes.The second edition has been completely revised and updated. There are 182 chapters, of which 55 are new.

Captures the latest information on lipid-lowering agents in a brand-new section that reflects the growing importance of these drugs.Expands the section on antithrombotic therapy to include several low molecular heparin derivatives.

Discusses new drug classes, including angiotensin receptor inhibitors, sinus note inhibtors, and cellular anti-ischaemic agents.Features an expert Editorial Board that rigorously reviews coverage to ensure state-of-the-art guidance.

Contents
Part One. Therapeutic Strategies in Patients and Diseases: Emerging Concepts in Cardiovascular Drug Therapy. Drug Treatment of Chronic Cardiovascular Disorders: Initial Therapy and Combination Therapy. Drug Treatment of Cardiovascular Emergencies. Special Clinical Situations. Part Two. Cardiovascular Drugs: Diuretics. Beta-Adrenoreceptor Blockers. Antiadrenergic Drugs. Angiotensin-Converting Enzyme Inhibitors. Angiotensin Inhibitors. Arteriolar and Venous Vasodilators. Calcium Entry Blockers. Lipid-Lowering Drugs. Positive Inotropic Agents. Antiarrhythmic Drugs. Antithrombotic Therapy. Cellular Anti-Ischemic Agents. Other Drugs for the Treatment of Cardiovascular Disorders.